Akebia Therapeutics (AKBA) Capital Leases (2013 - 2014)
Akebia Therapeutics (AKBA) reported Capital Leases of $6,369 for Q2 2014, down 13.5% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Capital Leases (2013 - 2014) Analysis & Trends
At the end of FY2013, Akebia Therapeutics posted Capital Leases of $8,004.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.02 Bn | 1,101.60 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn |
| 4 | Merck | 366.78 Bn | 321.16 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.44 Bn | 190.84 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.69 Bn | 164.89 Bn | 6.22 Bn |
| 9 | Pfizer | 169.52 Bn | 116.16 Bn | 10.94 Bn |
| 10 | Akebia Therapeutics | 155.86 Mn | -513.62 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2014 | 6,369.00 |
| Mar 31, 2014 | 7,364.00 |
| Dec 31, 2013 | 8,004.00 |
API Access
Akebia Therapeutics Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();